MaxCyte, Inc.

MXCT ·Healthcare, Diagnostics & Research, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $268.3M

Liabilities Breakdown FY2023

Total Liabilities: $36.1M